Kan He

7.7k total citations
109 papers, 5.8k citations indexed

About

Kan He is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Kan He has authored 109 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 29 papers in Pharmacology and 23 papers in Oncology. Recurrent topics in Kan He's work include Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (22 papers) and Natural product bioactivities and synthesis (20 papers). Kan He is often cited by papers focused on Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (22 papers) and Natural product bioactivities and synthesis (20 papers). Kan He collaborates with scholars based in United States, China and Germany. Kan He's co-authors include Naisheng Bai, Thomas F. Woolf, Qunyi Zheng, Chi‐Tang Ho, Guoen Shi, Jerry L. McLaughlin, Paul F. Hollenberg, Qun Yi Zheng, Bo Zheng and Marc Roller and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kan He

107 papers receiving 5.5k citations

Peers

Countries citing papers authored by Kan He

Since Specialization

Citations

This map shows the geographic impact of Kan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan He more than expected).

Fields of papers citing papers by Kan He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan He. The network helps show where Kan He may publish in the future.

Co-authorship network of co-authors of Kan He

This figure shows the co-authorship network connecting the top 25 collaborators of Kan He. A scholar is included among the top collaborators of Kan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kan He. Kan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid Screening of Chemical Components in Salvia miltiorrhiza with the Potential to Inhibit Skin Inflammation 2024 ·International Journal of Molecular Sciences ·Kan He, (unknown), Xiaolin Bai, Xun Liao	2
2	A characterized saponin-rich fraction of Momordica charantia shows antidiabetic activity in C57BLK/6 mice fed a high fat diet 2021 ·Phytomedicine Plus ·Amy C. Keller, Kan He, (unknown), Edward J. Kennelly	6
3	Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse 2016 ·Chemico-Biological Interactions ·Jie Zhang, Kan He, Lining Cai, Yu‐Chuan Chen, Yifan Yang, Qin Shi, Thomas F. Woolf, Weigong Ge, Lei Guo, Jürgen Borlak, Weida Tong	32
4	Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin 2012 ·Fitoterapia ·Linda Saxe Einbond, Hsan‐au Wu, (unknown), Kan He, Marc Roller, Tao Su, Xiaomei Wang, (unknown)	71
5	Importance of Extract Standardization and In Vitro/Ex Vivo Assay Selection for the Evaluation of Antioxidant Activity of Botanicals: A Case Study on Three Rosmarinus officinalis L. Extracts 2010 ·Journal of Medicinal Food ·Alvin Ibarra, Julien Cases, Antoine Bily, Kan He, Naisheng Bai, Marc Roller, (unknown), Christophe Ripoll	32
6	Tissue Distribution and Elimination of [14C]Apixaban in Rats 2010 ·Drug Metabolism and Disposition ·Lifei Wang, Kan He, Brad D. Maxwell, Scott Grossman, Larry M. Tremaine, W. Griffith Humphreys, Donglu Zhang	48
7	Metabolism, pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban in rabbits 2009 ·Journal of Thrombosis and Thrombolysis ·Donglu Zhang, Kan He, Nirmala Raghavan, Lifei Wang, Earl J. Crain, Bing He, Baomin Xin, Joseph M. Luettgen, Pancras C. Wong	17
8	Acute effects of Fraxinus excelsior L. seed extract on postprandial glycemia and insulin secretion on healthy volunteers 2009 ·Journal of Ethnopharmacology ·P. K. S. Visen, (unknown), (unknown), Marc Roller, Antoine Bily, C. Mermet, Kan He, Naisheng Bai, (unknown), Sophie Lafay, Alvin Ibarra	32
9	Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans 2009 ·Drug Metabolism and Disposition ·Donglu Zhang, Kan He, Nirmala Raghavan, Lifei Wang, James Mitroka, Brad D. Maxwell, Robert M. Knabb, Charles Frost, Alan Schuster, Hao Feng, Zhe-ming Gu, W. Griffith Humphreys, Scott Grossman	89
10	Lacteal Secretion, Fetal and Maternal Tissue Distribution of Dasatinib in Rats 2008 ·Drug Metabolism and Disposition ·Kan He, Michael W. Lago, Ramaswamy A. Iyer, (unknown), W. Griffith Humphreys, Lisa J. Christopher	43
11	Troglitazone Thiol Adduct Formation in Human Liver Microsomes: Enzyme Knietics and Reaction Phenotyping 2008 ·Drug Metabolism Letters ·Jinping Gan, (unknown), Bing He, Wen Chyi Shyu, A. David Rodrigues, Kan He	2
12	Reductive Isoxazole Ring Opening of the Anticoagulant Razaxaban Is the Major Metabolic Clearance Pathway in Rats and Dogs 2007 ·Drug Metabolism and Disposition ·Donglu Zhang, Nirmala Raghavan, Shiang-Yuan Chen, Haiying Zhang, Mimi L. Quan, (unknown), (unknown), Patrick Y. S. Lam, Samuel J. Bonacorsi, Robert M. Knabb, Gary L. Skiles, Kan He	46
13	Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer X. Qiao, Xuhong Cheng, Joanne M. Smallheer, Robert A. Galemmo, (unknown), Donald Pinto, Daniel L. Cheney, Kan He, Pancras C. Wong, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam	18
14	THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION 2004 ·Drug Metabolism and Disposition ·Harvey Wong, Scott Grossman, Stephen A. Bai, Sharon Diamond, Matthew Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram, David D. Christ	21
15	Bergamottin contribution to the grapefruit juice?felodipine interaction and disposition in humans 2004 ·Clinical Pharmacology & Therapeutics ·Theunis C. Goosen, (unknown), David G. Bailey, (unknown), Kan He, Paul F. Hollenberg, Patrick M. Woster, Lisa J. Cohen, John A. Williams, (unknown)	70
16	INCORPORATION OF AN OXYGEN FROM WATER INTO TROGLITAZONE QUINONE BY CYTOCHROME P450 AND MYELOPEROXIDASE 2004 ·Drug Metabolism and Disposition ·Kan He, Rasmy Talaat, Thomas F. Woolf	5
17	Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction☆ 2001 ·Biochemical Pharmacology ·Kan He, Thomas F. Woolf, Erick Kindt, (unknown), Rasmy Talaat	33
18	Cytochrome P450 2C11:Escherichia coliExpression, Purification, Functional Characterization, and Mechanism-Based Inactivation of the Enzyme 1997 ·Archives of Biochemistry and Biophysics ·(unknown), Kan He, Hequn Yin, Maria Almira Correia	20
19	Recent advances in annonaceous acetogenins 1996 ·Natural Product Reports ·Lu Zeng, Qing Ye, Nicholas H. Oberlies, Guoen Shi, Zhe-ming Gu, Kan He, Jerry L. McLaughlin	322
20	cis-Gigantrionenin and 4-acetyl gigantetrocin A, two new bioactive annonaceous acetogenins from Goniothalamus giganteus, and the stereochemistries of acetogenin 1,2,5-triols 1996 ·Bioorganic & Medicinal Chemistry ·Lu Zeng, Yan Zhang, Qing Ye, (unknown), Kan He, Jerry L. McLaughlin	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact